59 related articles for article (PubMed ID: 16527552)
1. Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells.
Liu SQ; Yu JP; Yu HG; Lv P; Chen HL
Dig Liver Dis; 2006 May; 38(5):310-8. PubMed ID: 16527552
[TBL] [Abstract][Full Text] [Related]
2. Low-frequency ERK and Akt activity dynamics are predictive of stochastic cell division events.
Bennett JJR; Stern AD; Zhang X; Birtwistle MR; Pandey G
NPJ Syst Biol Appl; 2024 Jun; 10(1):65. PubMed ID: 38834572
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects of human calprotectin on gastric cancer cell line is attenuated by etoposide.
Zali H; Zamanian-Azodi M; Shokrgozar MA; Rezaei-Tavirani M
Gastroenterol Hepatol Bed Bench; 2012; 5(3):132-8. PubMed ID: 24834214
[TBL] [Abstract][Full Text] [Related]
4. The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage.
Jin C; Einig E; Xu W; Kollampally RB; Schlosser A; Flentje M; Popov N
Nucleic Acids Res; 2024 Apr; 52(6):3011-3030. PubMed ID: 38227944
[TBL] [Abstract][Full Text] [Related]
5. A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer.
Ruan T; Liu W; Tao K; Wu C
Onco Targets Ther; 2020; 13():1797-1807. PubMed ID: 32184615
[TBL] [Abstract][Full Text] [Related]
6. GRK2 promotes growth of medulloblastoma cells and protects them from chemotherapy-induced apoptosis.
Pathania AS; Ren X; Mahdi MY; Shackleford GM; Erdreich-Epstein A
Sci Rep; 2019 Sep; 9(1):13902. PubMed ID: 31554835
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation panel for predicting etoposide resistance in small-cell lung cancer.
Qiu Z; Lin A; Li K; Lin W; Wang Q; Wei T; Zhu W; Luo P; Zhang J
Drug Des Devel Ther; 2019; 13():2021-2041. PubMed ID: 31417239
[TBL] [Abstract][Full Text] [Related]
8. InDePTH: detection of hub genes for developing gene expression networks under anticancer drug treatment.
Koido M; Tani Y; Tsukahara S; Okamoto Y; Tomida A
Oncotarget; 2018 Jun; 9(49):29097-29111. PubMed ID: 30018738
[TBL] [Abstract][Full Text] [Related]
9. CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer.
Ignacio RMC; Dong YL; Kabir SM; Choi H; Lee ES; Wilson AJ; Beeghly-Fadiel A; Whalen MM; Son DS
Oncotarget; 2018 Feb; 9(11):9751-9765. PubMed ID: 29515768
[TBL] [Abstract][Full Text] [Related]
10.
Lan KH; Lee WP; Wang YS; Liao SX; Lan KH
Oncotarget; 2017 Dec; 8(69):113460-113471. PubMed ID: 29371922
[TBL] [Abstract][Full Text] [Related]
11. Fascaplysin Sensitizes Anti-Cancer Effects of Drugs Targeting AKT and AMPK.
Oh TI; Lee JH; Kim S; Nam TJ; Kim YS; Kim BM; Yim WJ; Lim JH
Molecules; 2017 Dec; 23(1):. PubMed ID: 29295560
[TBL] [Abstract][Full Text] [Related]
12. POPX2 phosphatase regulates apoptosis through the TAK1-IKK-NF-κB pathway.
Weng T; Koh CG
Cell Death Dis; 2017 Sep; 8(9):e3051. PubMed ID: 28906490
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of chemoresistance in gastric cancer.
Shi WJ; Gao JB
World J Gastrointest Oncol; 2016 Sep; 8(9):673-81. PubMed ID: 27672425
[TBL] [Abstract][Full Text] [Related]
14. Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.
Gentilin E; Minoia M; Bondanelli M; Tagliati F; Degli Uberti EC; Zatelli MC
Endocrine; 2017 Jun; 56(3):621-632. PubMed ID: 27585662
[TBL] [Abstract][Full Text] [Related]
15. Hexamethylene amiloride engages a novel reactive oxygen species- and lysosome-dependent programmed necrotic mechanism to selectively target breast cancer cells.
Rowson-Hodel AR; Berg AL; Wald JH; Hatakeyama J; VanderVorst K; Curiel DA; Leon LJ; Sweeney C; Carraway KL
Cancer Lett; 2016 May; 375(1):62-72. PubMed ID: 26944316
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine alleviates etoposide-induced centrosome amplification by inhibiting CDK2 in adrenocortical tumor cells.
Chen TY; Syu JS; Lin TC; Cheng HL; Lu FL; Wang CY
Oncogenesis; 2015 Dec; 4(12):e180. PubMed ID: 26690546
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphisms of HER2 related to osteosarcoma susceptibility.
Xin DJ; Shen GD; Song J
Int J Clin Exp Pathol; 2015; 8(8):9494-9. PubMed ID: 26464710
[TBL] [Abstract][Full Text] [Related]
18. A literature mining-based approach for identification of cellular pathways associated with chemoresistance in cancer.
Oh JH; Deasy JO
Brief Bioinform; 2016 May; 17(3):468-78. PubMed ID: 26220932
[TBL] [Abstract][Full Text] [Related]
19. Expression of phosphorylated mTOR and its clinical significances in small cell lung cancer.
Lee JH; Kang KW; Lee HW
Int J Clin Exp Pathol; 2015; 8(3):2987-93. PubMed ID: 26045808
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment of PD98059 and DAPT in gastric cancer through induction of apoptosis and downregulation of WNT/β-catenin.
Yao J; Qian C; Shu T; Zhang X; Zhao Z; Liang Y
Cancer Biol Ther; 2013 Sep; 14(9):833-9. PubMed ID: 23792588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
